A 39-year-old man presented with bilateral nasal obstruction for 4 months and associated with hyposmia and foul-smelling nasal discharge. Nasal endoscopy showed irregular mucosa of the nasal cavity with easily bleeding. Nasal biopsy reported as extranodal Natural Killer/T cell lymphoma, nasal type. In-situ hybridisation for Epstein-Barr encoding region was positive. He was treated with six cycles of gemcitabine, oxaliplatin and L-asparaginase and peripheral blood stem cell transplant. After the treatment, he was asymptomatic until 9 months where he had splenic abscess and undergone splenectomy. He was asymptomatic of the disease for 2 years.
Ceruminous adenoma is described as a glandular neoplasm of ceruminous glands. It is seen for less than one percent of all external ear tumours. Ceruminous adenoma cases were reported to have recurrence and residual tumour, however there was no malignant transformation known in ceruminous adenoma up to this date. Here, we report a young adult woman with two years history of progressive reduced hearing and tinnitus of the right ear. She was proven to have right moderate conductive hearing loss with pure tone audiometry. There was a cystic mass with serous content arising from the posterior wall of the right ear canal. We proceeded with wide local excision of the mass via trans-canal approach. Ceruminous adenoma was confirmed with histopathology and immunohistochemistry of CK7 staining. The hearing impairment was resolved completely post excision and there was no recurrence of the tumour on one year follow-up. We concluded wide local excision with appropriate margin of the mass is adequate to prevent recurrence in ceruminous adenoma cases.
1 December 2021 in Turkish Archives of Otorhinolaryngology
Plexiform neurofibroma represents an uncommon variant of neurofibromatosis type 1, constituting only 5%–30% of all cases. Plexiform neurofibroma is usually diagnosed during childhood and arises from multiple nerves, manifesting as bulging and deforming masses that can also involve connective tissue and skin folds. We report a case of a two-year-old girl who presented with worsening stridor since birth and later exhibited progressively increasing left neck swelling at the age of 10 months old. Ultrasound and magnetic resonance imaging (MRI) showed a lobulated solid mass in the left deep neck space extending to the midline and having a mass effect on the airway with involvement of the supraglottic region. Tracheostomy was done, and a biopsy of the supraglottic lesion revealed a plexiform neurofibroma. The patient was conservatively managed after a discussion with her parents concerning the associated potential of operative morbidity. The patient’s parents had learned about tracheostomy care, and the patient was scheduled for yearly MRI surveillance. MRI was performed again three months after the initial diagnosis and showed stable lesion. Plexiform neurofibroma is a slow-growing tumor. A treatment decision must consider the benefits of surgery and the morbidity of the progressing disease. Hence, airway management is crucial prior to the final decision of such cases.
Introduction: Calcium phosphate cement (CPC) is a promising bone substitute but lacks osteogenicity and mechanical strength. This study investigated the effects of CPC doped with palm tocotrienol, a bone-protective agent, on bone regeneration in ovariectomised rats with tibial defects.Material and methods: Female Sprague-Dawley rats were divided into sham-operated controls, ovariectomised rats (OVX), ovariectomised rats with bone defects implanted with CPC (OVX + CPC) and ovariectomised rats with bone defects implanted with palm tocotrienol-doped CPC (OVX + CPC/T3). A tibial bone defect was created 11 weeks after ovariectomy.Results: Whole-body BMC was higher in OVX + CPC (10.89 ±0.07 g) and OVX + CPC/T3 (11.26 ±0.07 g) than OVX (10.24 ±0.14 g) (p < 0.05). Whole-body BMD of OVX + CPC/T3 (0.175 ±0.003 to 0.182 ±0.003 g/cm2), left tibia BMC of OVX + CPC (0.308 ±0.016 to 0.343 ±0.022 g) and OVX + CPC/T3 (0.313 ±0.020 to 0.343 ±0.016 g) increased from week 11 to 15 (p < 0.05). The OVX + CPC/T3 group had higher bone stiffness (23.31 ±1.07 vs. 8.35 ±3.84 N/mm), collagen (scoring: 3 ±0.75 vs. 2 ±0), trabecular bone formation (scoring: 3 ±0 vs. 2 ±0), and trabecular bone volume (36.30 ±3.58 vs. 20.86 ±1.03%) but lower osteoclast surface (1.65 ±0.49 vs. 6.60 ±1.36%) than OVX (p < 0.05). Tibial BMP-2 in OVX + CPC/T3 (78.96 ±8.30 pg/mg protein) was higher than OVX (30.65 ±3.69 pg/mg protein) and OVX + CPC (48.09.96 ±8.39 pg/mg protein) (p < 0.05). Tibial Runx-2 in OVX + CPC/T3 (2589.75 ±204.74 pg/mg protein) was higher than OVX (1652.97 ±156.85 pg/mg protein) and OVX + CPC (1845.77 ±158.17 pg/mg protein) (p < 0.05).Conclusions: Palm tocotrienol enhanced the osteogenic properties of CPC, promoting collagen and trabecular bone formation in ovariectomised rats with bone defects. These findings suggest its potential to overcome the drawbacks of CPC and promote bone regeneration.